TY - T1的理解代谢疾病并发症的病理生理机制在阻塞性睡眠呼吸暂停对个性化治疗方法JF -欧洲呼吸杂志》乔和J - 10.1183/13993003.02295 -2019欧元SP - 1902295 AU -瑞安Silke盟Eoin p·康明斯盟Ramon Farre AU -亚历克斯Gileles-Hillel盟Jonathan c君非盟-亨利克·奥斯特盟jean - louis Pepin AU -大卫·w·雷盟Sirimon Reutrakul AU - Manuel Sanchez-de-la-Torre盟Renaud Tamisier AU -艾萨克Almendros Y1 - 2020/01/01 UR - //www.qdcxjkg.com/content/early/2020/03/17/13993003.02295 - 2019. -抽象N2 - 2019年1月,《欧洲呼吸学会(ERS)研究研讨会”目标的不利影响睡眠障碍和障碍”在都柏林,爱尔兰。188bet官网地址它提供机会仔细审阅当前睡眠障碍的病理生理反应的证据,如睡眠不足、睡眠破碎或生理失调和生理的异常气体氧气和二氧化碳等经常发生在睡眠时呼吸条件。一个特定的研讨会的重点是放在知识的当前状态的评估心血管和代谢疾病的病理生理学阻塞性睡眠呼吸暂停(OSA)。识别这些过程的详细机制领域占有十分重要的地位,本课程提供了一个理想的平台交换知识,讨论当前模型的缺陷和未来合作的设计研究。我们也讨论目前的治疗策略的局限性代谢疾病并发症在阻塞性睡眠呼吸暂停综合症和讨论潜在有价值的替代方法。FootnotesThis手稿最近发表在《欧洲呼吸杂志》上。这里发表周全之前接受的形式排版,我们的生产团队。这些生产过程完成后,作者已经批准结果证明,本文将最新一期的ERJ在线。请打开或下载PDF查看这篇文章。利益冲突:瑞安博士没有披露。利益冲突:康明斯博士没有披露。利益冲突:Farre博士没有披露。Conflict of interest: Dr. Gileles-Hillel has nothing to disclose.Conflict of interest: Dr. Jun has nothing to disclose.Conflict of interest: Dr. Oster has nothing to disclose.Conflict of interest: Dr. Pepin has nothing to disclose.Conflict of interest: Dr. ray has nothing to disclose.Conflict of interest: Dr. Reutrakul reports grants from Merck Sharp and Dohme, personal fees from Medtronic, personal fees from Sanofi Aventis, outside the submitted work.Conflict of interest: Dr. Sanchez-de-la-Torre has nothing to disclose.Conflict of interest: Dr. Tamisier reports other from Agiradom, grants from Resmed, personal fees from Resmed, personal fees from Philips, personal fees from Elivie, personal fees from Navigant, personal fees from Inspire, personal fees from Jazz pharmaceutical, personal fees from Resmed, from null, outside the submitted work.Conflict of interest: Dr. Isaac Almendros has nothing to disclosure ER -